Detalles de la búsqueda
1.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Antimicrob Agents Chemother
; 67(8): e0041423, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428034
2.
Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach.
Mol Pharm
; 20(3): 1509-1518, 2023 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36512679
3.
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
J Antimicrob Chemother
; 77(7): 1923-1930, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470370
4.
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
Int J Antimicrob Agents
; 62(3): 106887, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315906
5.
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.
Int J Antimicrob Agents
; 53(5): 589-597, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30639526
Resultados
1 -
5
de 5
1
Próxima >
>>